Today's guest is Nicole Baker, CEO at biologit. Founded around 2020, biologit - who was a finalist in the Best Application of AI in Healthcare at the 2024 AI Awards - has pioneered an innovative approach to pharmacovigilance, the practice of monitoring the effects of medical drugs after they have been licensed for use.
Topics include:
0:00 Applying AI and NLP to analyze pharmaceutical literature efficiently
3:06 Helping pharma companies and service providers save time
4:10 Building AI with open-access literature to analyze unstructured data
6:18 How Gen AI isn’t fully validated for pharmacovigilance compliance
9:14 Pharma adoption of AI is slow due to learning and change management
11:19 How AI streamlines event detection and global biomedical data monitoring
14:19 Signing 12 new contracts, expanding to top pharma
AI Ireland with Mark Kelly